Jiangsu Hengrui Medicine Co Ltd (600276) — Cash Flow Quality Index
Jiangsu Hengrui Medicine Co Ltd (600276) has a Cash Flow Quality Index of 3.70x as of September 2025. Operating cash flow of CN¥4.81 Billion exceeds net income of CN¥1.30 Billion, indicating high earnings quality where cash backs reported profits. Explore cash efficiency ratio of Jiangsu Hengrui Medicine Co Ltd to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Jiangsu Hengrui Medicine Co Ltd Cash Flow Quality Index (1999–2024)
Historical Cash Flow Quality Index for Jiangsu Hengrui Medicine Co Ltd across 26 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check cash flow reinvestment rate of Jiangsu Hengrui Medicine Co Ltd to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Jiangsu Hengrui Medicine Co Ltd (1999–2024)
Year-by-year earnings quality comparison for Jiangsu Hengrui Medicine Co Ltd. For live market cap and the full company financial profile, see how much is Jiangsu Hengrui Medicine Co Ltd worth.
| Year | Quality Index | Operating CF (CNY) | Net Income | YoY Change |
|---|---|---|---|---|
| 2024 | 1.17x | CN¥7.42 Billion | CN¥6.34 Billion | ▼ -34.4% |
| 2023 | 1.79x | CN¥7.64 Billion | CN¥4.28 Billion | ▲ +438.8% |
| 2022 | 0.33x | CN¥1.27 Billion | CN¥3.82 Billion | ▼ -64.8% |
| 2021 | 0.94x | CN¥4.22 Billion | CN¥4.48 Billion | ▲ +73.0% |
| 2020 | 0.54x | CN¥3.43 Billion | CN¥6.31 Billion | ▼ -24.1% |
| 2019 | 0.72x | CN¥3.82 Billion | CN¥5.33 Billion | ▲ +4.9% |
| 2018 | 0.68x | CN¥2.77 Billion | CN¥4.06 Billion | ▼ -11.7% |
| 2017 | 0.77x | CN¥2.55 Billion | CN¥3.29 Billion | ▼ -21.4% |
| 2016 | 0.98x | CN¥2.59 Billion | CN¥2.63 Billion | ▼ -3.9% |
| 2015 | 1.02x | CN¥2.28 Billion | CN¥2.22 Billion | ▲ +2.3% |
| 2014 | 1.00x | CN¥1.57 Billion | CN¥1.57 Billion | ▼ -5.3% |
| 2013 | 1.06x | CN¥1.36 Billion | CN¥1.29 Billion | ▲ +26.9% |
| 2012 | 0.83x | CN¥958.37 Million | CN¥1.15 Billion | ▲ +48.4% |
| 2011 | 0.56x | CN¥527.36 Million | CN¥940.41 Million | ▲ +9.8% |
| 2010 | 0.51x | CN¥385.95 Million | CN¥755.44 Million | ▼ -19.3% |
| 2009 | 0.63x | CN¥439.12 Million | CN¥693.30 Million | ▲ +134.9% |
| 2008 | 0.27x | CN¥117.46 Million | CN¥435.59 Million | ▼ -48.4% |
| 2007 | 0.52x | CN¥218.87 Million | CN¥418.53 Million | ▼ -59.7% |
| 2006 | 1.30x | CN¥266.18 Million | CN¥204.90 Million | ▼ -8.7% |
| 2005 | 1.42x | CN¥227.88 Million | CN¥160.07 Million | ▼ -17.5% |
| 2004 | 1.73x | CN¥209.41 Million | CN¥121.32 Million | ▲ +16.3% |
| 2003 | 1.48x | CN¥136.82 Million | CN¥92.20 Million | ▲ +136.0% |
| 2002 | 0.63x | CN¥49.84 Million | CN¥79.27 Million | ▲ +345.5% |
| 2001 | 0.14x | CN¥11.49 Million | CN¥81.40 Million | ▼ -52.8% |
| 2000 | 0.30x | CN¥19.61 Million | CN¥65.54 Million | ▼ -54.4% |
| 1999 | 0.66x | CN¥33.89 Million | CN¥51.65 Million | — |